FR2457295A1 - Composes intermediaires pour la preparation de cephalosporines - Google Patents

Composes intermediaires pour la preparation de cephalosporines

Info

Publication number
FR2457295A1
FR2457295A1 FR8011530A FR8011530A FR2457295A1 FR 2457295 A1 FR2457295 A1 FR 2457295A1 FR 8011530 A FR8011530 A FR 8011530A FR 8011530 A FR8011530 A FR 8011530A FR 2457295 A1 FR2457295 A1 FR 2457295A1
Authority
FR
France
Prior art keywords
cephalosporins
preparation
dichlorhydrate
intermediate compounds
ceph
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8011530A
Other languages
English (en)
Other versions
FR2457295B1 (fr
Inventor
William Reginald Jones
Harish Shivprasad Trivedi
Timothy Larry Gane
John Malcolm Robinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of FR2457295A1 publication Critical patent/FR2457295A1/fr
Application granted granted Critical
Publication of FR2457295B1 publication Critical patent/FR2457295B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/18—7-Aminocephalosporanic or substituted 7-aminocephalosporanic acids

Abstract

L'INVENTION CONCERNE DES CEPHEMES. L'INVENTION A PLUS PARTICULIEREMENT POUR OBJET LE DICHLORHYDRATE DE (6R, 7R)-7-AMINO-3- (1-PYRIDINIUM-METHYL) CEPH-3-EME-4-CARBOXYLATE. L'INVENTION CONCERNE AUSSI LES SOLVATES DU DICHLORHYDRATE DE (6R, 7R)-7-AMINO-3- (1-PYRIDINIUMMETHYL) CEPH-3-ENE-4-CARBOXYLATE, AINSI QUE LE DIHYDRATE DU DICHLORHYDRATE PRECITE. ON OBTIENT LE COMPOSE EN QUESTION PAR UNE REACTION DE DESACYLATION. LE COMPOSE OBTENU EST UN INTERMEDIAIRE POUR LA PREPARATION DE CEPHALOSPORINES.
FR8011530A 1979-05-25 1980-05-23 Composes intermediaires pour la preparation de cephalosporines Granted FR2457295A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7918428 1979-05-25

Publications (2)

Publication Number Publication Date
FR2457295A1 true FR2457295A1 (fr) 1980-12-19
FR2457295B1 FR2457295B1 (fr) 1983-11-10

Family

ID=10505477

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8011530A Granted FR2457295A1 (fr) 1979-05-25 1980-05-23 Composes intermediaires pour la preparation de cephalosporines

Country Status (10)

Country Link
US (3) US4369313A (fr)
JP (2) JPS5612397A (fr)
BE (1) BE883453A (fr)
CH (1) CH654010A5 (fr)
DE (1) DE3019838A1 (fr)
FR (1) FR2457295A1 (fr)
GB (1) GB2052490B (fr)
IT (1) IT1145686B (fr)
NL (1) NL8003003A (fr)
ZA (1) ZA803093B (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0070706A2 (fr) * 1981-07-17 1983-01-26 Glaxo Group Limited Dérivés de céphalosporine
EP0135258A2 (fr) * 1983-06-20 1985-03-27 Eli Lilly And Company 7-(R)-Amino-3-(1-pyridiniumméthyle)-céph-3-em-4-carboxylique cristallin
EP0175544A2 (fr) * 1984-09-17 1986-03-26 Eli Lilly And Company Procédé pour la préparation d'intermédiaires de céphalosporine
EP0222577A2 (fr) * 1985-11-06 1987-05-20 Eli Lilly And Company Céphalosporine cristalline monohydratée
EP0233271A1 (fr) * 1985-08-20 1987-08-26 Bristol Myers Co Procede de preparation d'intermediaires de cephalosporine.
EP0587121A1 (fr) * 1992-09-08 1994-03-16 Bristol-Myers Squibb Company Dihydrate cristallisé d'un dihydrochlorure de céphalosporine et ses compositions injectables
EP0612750A2 (fr) * 1984-11-23 1994-08-31 BIOCHEMIE Gesellschaft m.b.H. Dérivés de céphalosporine

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5612397A (en) * 1979-05-25 1981-02-06 Glaxo Group Ltd Intermediate for manufacture of cephalosporin antibiotic
JPS5657789A (en) * 1979-10-02 1981-05-20 Glaxo Group Ltd Novel cephalosporin antibiotic
JPS5859991A (ja) * 1981-09-14 1983-04-09 Fujisawa Pharmaceut Co Ltd 新規セフェム化合物
EP0113568B1 (fr) * 1982-12-27 1990-04-04 Eli Lilly And Company Intermédiaires pour la préparation de ceftazidine, et procédé pour leur préparation
DE3248281A1 (de) * 1982-12-28 1984-06-28 Hoechst Ag, 6230 Frankfurt Kristalisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung
DE3419014A1 (de) * 1984-05-22 1985-11-28 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 7-amino-3-(3-formamidopyridinium)methyl-3-cephem-4-carboxylat und verwendung zur synthese von ss-lactamantibiotika
JPS6160296A (ja) * 1984-08-30 1986-03-27 Yoshitsuka Seiki:Kk 全自動粉末成形プレス
JPH0649707B2 (ja) * 1985-03-01 1994-06-29 第一製薬株式会社 ３−ピリジニウムメチルセフエム誘導体
US4703118A (en) * 1985-04-08 1987-10-27 Eli Lilly And Company Synthesis of 3-iodomethyl cephalosporins
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
US4665168A (en) * 1986-04-14 1987-05-12 Eli Lilly And Company Cephalosporin intermediate
KR100342600B1 (ko) 2000-03-06 2002-07-04 한미정밀화학주식회사 신규한 티아졸 화합물 및 그의 제조 방법
KR100392409B1 (ko) 2000-03-20 2003-07-22 한미정밀화학주식회사 신규한 티아졸 화합물을 이용한 세팔로스포린계항생물질의 제조 방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB953695A (en) 1959-08-04 1964-03-25 Nat Res Dev Derivatives of cephalosporin c
BE638034A (fr) * 1962-10-03
GB1028563A (en) 1962-12-14 1966-05-04 Glaxo Lab Ltd Antibacterial derivative of 7-aminocephalosporanic acid
GB1052068A (fr) * 1963-11-04
US3422099A (en) * 1966-02-18 1969-01-14 Bristol Myers Co 7-(alpha-hydroxy-(2' or 3'-thienyl)-acetamido) cephalosporanic acids and related salts and derivatives
GB1522140A (en) * 1974-12-20 1978-08-23 Glaxo Lab Ltd Syn-7-(2-hydroxyiminoacetamido)-3-pyridiniummethyl cephalosporins methods for their preparation and compositions containing them
NL162387C (nl) * 1977-09-06 1980-05-16 Gist Brocades Nv Werkwijze voor het bereiden van 6-(d-alpha-amino-p- -hydroxyfenylacetamido)penicillanzuur.
AR229883A1 (es) * 1978-05-26 1983-12-30 Glaxo Group Ltd Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato
GB2058791B (en) * 1978-05-26 1982-11-24 Glaxo Group Ltd Cephalosporin antibiotics
JPS5612397A (en) * 1979-05-25 1981-02-06 Glaxo Group Ltd Intermediate for manufacture of cephalosporin antibiotic
JPS5657789A (en) * 1979-10-02 1981-05-20 Glaxo Group Ltd Novel cephalosporin antibiotic

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0070706A2 (fr) * 1981-07-17 1983-01-26 Glaxo Group Limited Dérivés de céphalosporine
EP0070706A3 (en) * 1981-07-17 1984-04-25 Glaxo Group Limited Cephalosporin compounds
EP0135258A2 (fr) * 1983-06-20 1985-03-27 Eli Lilly And Company 7-(R)-Amino-3-(1-pyridiniumméthyle)-céph-3-em-4-carboxylique cristallin
EP0135258A3 (en) * 1983-06-20 1985-12-18 Eli Lilly And Company Improvements in or relating to a crystalline 7-(r)-amino-3-(1-pyridiniummethyl)-ceph-3-em-4-carboxylate
EP0175544A3 (fr) * 1984-09-17 1987-06-03 Eli Lilly And Company Procédé pour la préparation d'intermédiaires de céphalosporine
EP0175544A2 (fr) * 1984-09-17 1986-03-26 Eli Lilly And Company Procédé pour la préparation d'intermédiaires de céphalosporine
EP0612750A2 (fr) * 1984-11-23 1994-08-31 BIOCHEMIE Gesellschaft m.b.H. Dérivés de céphalosporine
EP0612750A3 (en) * 1984-11-23 1994-09-28 Biochemie Gmbh Cephalosporinderivatives.
EP0233271A1 (fr) * 1985-08-20 1987-08-26 Bristol Myers Co Procede de preparation d'intermediaires de cephalosporine.
EP0233271A4 (fr) * 1985-08-20 1988-10-20 Bristol Myers Co Procede de preparation d'intermediaires de cephalosporine.
EP0222577A2 (fr) * 1985-11-06 1987-05-20 Eli Lilly And Company Céphalosporine cristalline monohydratée
EP0222577A3 (fr) * 1985-11-06 1988-10-05 Eli Lilly And Company Céphalosporine cristalline monohydratée
EP0587121A1 (fr) * 1992-09-08 1994-03-16 Bristol-Myers Squibb Company Dihydrate cristallisé d'un dihydrochlorure de céphalosporine et ses compositions injectables

Also Published As

Publication number Publication date
NL8003003A (nl) 1980-11-27
DE3019838A1 (de) 1980-12-04
US4433141A (en) 1984-02-21
JPH0242085A (ja) 1990-02-13
IT8048772A0 (it) 1980-05-23
BE883453A (fr) 1980-11-24
GB2052490A (en) 1981-01-28
JPH0250914B2 (fr) 1990-11-05
US4374983A (en) 1983-02-22
IT1145686B (it) 1986-11-05
GB2052490B (en) 1983-09-07
CH654010A5 (de) 1986-01-31
ZA803093B (en) 1981-07-29
FR2457295B1 (fr) 1983-11-10
JPS5612397A (en) 1981-02-06
US4369313A (en) 1983-01-18

Similar Documents

Publication Publication Date Title
FR2457295A1 (fr) Composes intermediaires pour la preparation de cephalosporines
IE790292L (en) Dehydrocyclicimino acids.
PT75140B (en) Process for the preparation of detergent compositions containi ng carboxilic acid anphoteric-alcoxilated complexes
ES8502445A1 (es) Procedimiento para la preparacion de compuestos cefemicos
JPS5564571A (en) Novel 1*44dihydropyridine compound having substituted ester group
IE822648L (en) 7-oxabicycloheptane and 7-oxabicycloheptene compounds.
FR2371449A1 (fr) Acide 1-carba-2-penem-3-carboxylique
IL93999A0 (en) Naphthalenecarboxylic acid intermediates for the production of podophyllotoxin and related compounds and their preparation
ES8706654A1 (es) Un procedimiento para la preparacion de nuevos derivados de benzotiazina
JPS543087A (en) Preparation of cephalosporin compound
AU532435B2 (en) Dental compositions
ES529223A0 (es) Un procedimiento de preparacion de imino-2-pirrolidinas.
AU568064B2 (en) 4-acylamino-1-aza-adamantanes
FR2355848A1 (fr) 7-(a-(2,3-dihydro-2-oxobenzimidazol-1-yl-carbonylamino) arylacetamido) cephalosporines
EP0075024A4 (fr) Procede pour la preparation de compositions de nitrocellulose.
ZA832328B (en) Substituted hydroxyalkyl-azoles a process for their preparation and their use as antimycotics
AU568694B2 (en) N-benzyl-n-phenyl-b-pyrrolidinyl-f-isobutoxy-propylamine
FR2453176A1 (fr) Procede de preparation de cephalosporines substituees par un groupe carbamoyloxymethyle en position 3
JPS5282791A (en) Preparation of 7-amino compounds
AU532662B2 (en) Manufacture of med. c ferro-manganese
DE3277870D1 (en) Cephalosporin compounds
IT1141936B (it) Composti tiazolino azetidinonici che sono intermedi per la preparazione di cefalosporine
FR2426693A1 (fr) Antibiotique du type cephalosporine et son procede de preparation
FR2452497A1 (fr) Fortimicine an et son application comme intermediaire dans la synthese d'antibiotiques
FR2378782A1 (fr) Derives de diazatetracyclo-dodecanes utiles comme intermediaires de preparation

Legal Events

Date Code Title Description
ST Notification of lapse